Kirsteen J Campbell

15PUBLICATIONS
52CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyHaematological tumoursMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 06, 2026
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

|Jul 29, 2025
Apoptotic cells promote circulating tumor cell survival and metastasis.

Cassidy E Hagan, Valerie M Sheehan, Charles M Rezanka

|Feb 25, 2023
The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context.

Adiba S Khan, Kirsteen J Campbell, Ewan R Cameron

|Feb 03, 2023
Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function.

Alvaro Román-Fernández, Mohammed A Mansour, Fernanda G Kugeratski

|Apr 27, 2022
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics.

Anna L Koessinger, Catherine Cloix, Dominik Koessinger

|Mar 29, 2022
MCL-1 is a clinically targetable vulnerability in breast cancer.

Matthew L Winder, Kirsteen J Campbell

Pageof 3

Frequent Collaborators

11 joint publications

Karen Blyth

5 joint publications

Stephen W G Tait

3 joint publications

Florian J Bock

3 joint publications

Colin Nixon